Official UK procurement notice
Supply of anti-body contact tracing support
Authority: Department of Health & Social Care (Central government)
What is being bought
Published requirement descriptionSupporting existing PHE labs for data anlaysis support for contact tracing.
CPV: Data analysis services
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 15 Feb 2021, 16:43 GMT
- Last source update
- 15 Feb 2021, 16:43 GMT
- FTS notice number
2021/S 000-003044- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02934bFind a Tender
- Why no open competition
Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
- Published justification
The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.COVID-19 is serious and its consequences pose a risk to life. Cabinet Office published PPN 01/20: Responding to COVID-19 on procuring with extreme urgency in March 2020 which states that contracting authorities may enter into contracts withoutcompeting or advertising the requirement where certain tests are met.1) There are genuine reasons for extreme urgency as there is a significant public health risk requiring immediate action as a result of COVID-19 2) The COVID-19 situation is novel and the Contracting Authority could not have reasonably foreseen these events3) It is not possible to comply with the timescales of another procedure due to the urgent requirement to obtain the services required for antibody testing being contracted for. Additionally, there are many buyers competing for the same supplies. It is imperative that security of supply is maintained. Demand for equipment is high and there is little or no incentive for suppliers to participate in competitive procurement procedures.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| FD Technologies Plc | £568,701 † | — | Awarded |
Contracts
Contract 003044-2021-1 · FD Technologies Plc
- Signed
- 18 Jan 2021
- Value
- £568,701
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- First Derivatives PLCAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.